|
Companies |
The generic drugs sector is one of the most competitive to be found. Consolidation among major players has been common, and market share is being concentrated in fewer, larger companies. Understanding their performance, plans, products and prospects is vital for competitors, the branded drug industry and investors alike. For each company where available or appropriate, the following is covered:
|
|
|
|
Fuelled by the number of therapeutically significant products coming off patent, and the increasing pressure on drug costs by health payers the sector continues to grow in importance. Analysts in industry and commerce must have a clear understanding of the threats and opportunities in key markets worldwide, which is why Espicom’s incisive market analysis is vital. Each market report provide:
|
 Market growth and five-year forecasts
Detailed regulatory, pricing, reimbursement and IP appraisal
Extensive background data that places generic drugs in their market context
|
|
|
|
